Literature DB >> 8414514

Characterization of the transcriptional regulatory region of the human WT1 gene.

W Hofmann1, H D Royer, M Drechsler, S Schneider, B Royer-Pokora.   

Abstract

Specific control of the expression of the Wilms tumor gene WT1 is important for normal development of the kidney. In order to characterise the transcriptional control region of the WT1 gene we have isolated genomic clones spanning the upstream region, the first WT1 exon and the 5' end of the Wit1 gene. DNA sequencing revealed that the WT1 promoter lacks a TATA box or CCAAT motif and has a GC content of 71%. Four transcriptional start sites are clustered within a 32 bp region. GC-boxes are present at nucleotide positions -413, -160, +84 and +158. DNAase I protection assays with purified Sp1 protein revealed the existence of 11 different binding sites in the WT1 promoter. WT1 and Wit1 promoter activities were tested in COS-7 cells with luciferase reporter gene constructs either containing or lacking an SV40 enhancer. WT1 promoter activity was found in a fragment extending from 449 bp upstream to 201 bp downstream of the WT1 start site. It was 26 fold lower in the absence of the SV40 enhancer than in the presence. Cotransfection with a Sp1 expression vector stimulated both constructs 3-4 fold. Wit1 promoter activity was identified in a DNA fragment extending from 200 bp upstream of the putative Wit1 TATA box to 130 bp downstream. Several potential recognition sites for WT1/EGR, Pax-8, and GAGA-like transcription factors are present in the WT1 promoter.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8414514

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Overlapping DNA recognition motifs between Sp1 and a novel trans-acting factor within the wt1 tumour suppressor gene promoter.

Authors:  M T Discenza; M Dehbi; J Pelletier
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

2.  PAX8-mediated activation of the wt1 tumor suppressor gene.

Authors:  M Dehbi; J Pelletier
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

3.  Fine structure analysis of the WT1 gene in sporadic Wilms tumors.

Authors:  R Varanasi; N Bardeesy; M Ghahremani; M J Petruzzi; N Nowak; M A Adam; P Grundy; T B Shows; J Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

4.  Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer.

Authors:  Anthony R Dallosso; Anne L Hancock; Sally Malik; Ashreena Salpekar; Linda King-Underwood; Kathy Pritchard-Jones; Jo Peters; Kim Moorwood; Andrew Ward; Karim T A Malik; Keith W Brown
Journal:  RNA       Date:  2007-10-16       Impact factor: 4.942

Review 5.  Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1).

Authors:  Eneda Toska; Stefan G E Roberts
Journal:  Biochem J       Date:  2014-07-01       Impact factor: 3.857

6.  TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels.

Authors:  Mohammad Shahidul Makki; Thorsten Heinzel; Christoph Englert
Journal:  Nucleic Acids Res       Date:  2008-06-04       Impact factor: 16.971

Review 7.  The development of the kidney.

Authors:  J A Davies; J B Bard
Journal:  Curr Top Dev Biol       Date:  1998       Impact factor: 4.897

8.  The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.

Authors:  Youqi Han; Serban San-Marina; Lin Yang; Haytham Khoury; Mark D Minden
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.